ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 569,65
-0,83%
Dow Jones
40 211,72
0,53%
DAX
18 466,74
-0,72%
Brent Oil
83,595
-0,88%
Bitcoin
62 662,79
-3,38%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Intellia Therapeutics Inc (NTLA)

  7. Intellia Therapeutics Inc (NTLA) Actualités

NTLA

Intellia Therapeutics (NTLA)

Intellia Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NTLA
DateHeureSourceTitreSymboleSociété
14/05/201813h30GlobeNewswire Inc.New Scientific Advisors Focused on Cell Therapy in Immuno-Oncology and Autoimmunity Join Intellia TherapeuticsNASDAQ:NTLAIntellia Therapeutics Inc
02/05/201823h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
02/05/201815h09GlobeNewswire Inc.Intellia Therapeutics Announces First Quarter 2018 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
01/05/201813h48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTLAIntellia Therapeutics Inc
01/05/201813h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
01/05/201813h16Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NTLAIntellia Therapeutics Inc
27/04/201822h16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NTLAIntellia Therapeutics Inc
23/04/201815h29GlobeNewswire Inc.UPDATE -- Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell The...NASDAQ:NTLAIntellia Therapeutics Inc
23/04/201814h30GlobeNewswire Inc.Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st ...NASDAQ:NTLAIntellia Therapeutics Inc
17/04/201813h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NTLAIntellia Therapeutics Inc
23/03/201822h30Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NTLAIntellia Therapeutics Inc
14/03/201813h06Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NTLAIntellia Therapeutics Inc
14/03/201812h30GlobeNewswire Inc.Intellia Therapeutics Announces Fourth Quarter and Full Year 2017 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
28/02/201822h30GlobeNewswire Inc.Intellia Therapeutics to Present at March Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
27/02/201815h28GlobeNewswire Inc.Intellia Therapeutics Announces Publication in Cell Reports of Preclinical Data Demonstrating Effective CRISPR/Cas9 Genome Ed...NASDAQ:NTLAIntellia Therapeutics Inc
13/02/201815h55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTLAIntellia Therapeutics Inc
31/01/201822h30GlobeNewswire Inc.Intellia Therapeutics to Present at February Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
18/12/201713h30GlobeNewswire Inc.Intellia Therapeutics Names John Leonard, M.D., President and Chief Executive OfficerNASDAQ:NTLAIntellia Therapeutics Inc
11/12/201713h00GlobeNewswire Inc.Intellia Therapeutics Announces New, Robust Genome Editing Data for Sickle Cell Disease at the American Society of Hematology...NASDAQ:NTLAIntellia Therapeutics Inc
03/11/201711h05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NTLAIntellia Therapeutics Inc
02/11/201721h30GlobeNewswire Inc.Intellia Therapeutics to Present at November Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
02/11/201702h00GlobeNewswire Inc.Intellia Therapeutics Announces Pricing of Public Offering of Common StockNASDAQ:NTLAIntellia Therapeutics Inc
01/11/201712h00GlobeNewswire Inc.Intellia Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:NTLAIntellia Therapeutics Inc
31/10/201712h30GlobeNewswire Inc.Intellia Therapeutics Announces Third Quarter 2017 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
30/10/201721h35GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2017 EarningsNASDAQ:NTLAIntellia Therapeutics Inc
03/10/201722h35GlobeNewswire Inc.Intellia Therapeutics to Present at October Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
26/09/201713h30GlobeNewswire Inc.Intellia Therapeutics Demonstrates Sustained and Durable Genome Editing with CRISPR/Cas9 in One-Year Animal StudyNASDAQ:NTLAIntellia Therapeutics Inc
07/09/201723h00GlobeNewswire Inc.Intellia Therapeutics to Present at Upcoming September Investor Healthcare ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
01/08/201713h30GlobeNewswire Inc. Intellia Therapeutics Announces Second Quarter 2017 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
25/07/201723h00GlobeNewswire Inc.CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appellate Brief Seeking Reversal of...NASDAQ:NTLAIntellia Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NTLA

Dernières Valeurs Consultées

BIT
P23OA6
NLBNPIT23OA6 20241220 0.94
COIN
NXTGBP
Nxt
EU
REN
RELX
BIT
P23PG0
NLBNPIT23PG0 20991231 66...
TSXV
CLD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés